A double-blind study of the discontinuation of ragweed immunotherapy

Journal of Allergy and Clinical Immunology

Volumn 100, Issue 3, 1997, Pages 293-300

  Naclerio, Robert M ^a,b   Proud, David ^a   Moylan, Birgitta ^a   Balcer, Susan ^a   Freidhoff, Linda ^a   Kagey Sobotka, Anne ^a   Lichtenstein, Lawrence M ^a   Creticos, Peter S ^a   Hamilton, Robert G ^a   Norman, Philip S ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Allergic rhinitis; Discontinuation of immunotherapy; IgE antibodies; IgG antibodies; Ragweed immunotherapy

Indexed keywords

ALLERGIC RHINITIS; ALLERGY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; IMMUNOTHERAPY; NOSE MUCUS; PRIORITY JOURNAL; RAGWEED; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 9844246986     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0091-6749(97)70240-9     Document Type: Article

References (39)

1. Norman PS. Safety of allergen immunotherapy [editorial]. J Allergy Clin Immunol 1989;84:438-9.
2. Gleich GJ, Zimmerman BS, Henderson LL, Yunginger JW. Effects of immunotherapy on immunoglobulin E and immunoglobulin G antibodies to ragweed antigens: a six year prospective study. J Allergy Clin Immunol 1982;70:261-71.
3. Lichtenstein LM, Ishizaka K, Norman PS, Sobotka AK, Hill BM. IgE antibody measurements in ragweed hay fever. Relationship to clinical severity and the results of immunotherapy. J Clin Invest 1973;52:472-82.
4. Peng Z, Naclerio RM, Norman PS, Adkinson NF Jr. Quantitative IgE- and IgG-subclass responses during and after long-term ragweed immunotherapy. J Allergy Clin Immunol 1992;89:519-29.
5. Platts-Mills TA, von Maur RK, Ishizaka K, Norman PS, Lichtenstein LM. IgA and IgG anti-ragweed antibodies in nasal secretions. Quantitative measurements of antibodies and correlation with inhibition of histamine release. J Clin Invest 1976;57:1041-50.
6. Rocklin RE, Sheffer AL, Greineder DK, Melmon KL. Generation of antigen-specific suppressor cells during allergy desensitization. N Engl J Med 1980;302:1213-9.
7. Hsieh KH. Altered interleukin-2 (IL-2) production and responsiveness after hyposensitization to house dust. J Allergy Clin Immunol 1985;76:291-4.
8. Alam R, Forsythe PA, Lett-Brown MA, Grant JA. Study of the cellular origin of histamine release inhibitory factor using highly purified subsets of mononuclear cells. J Immunol 1989;143:2280-4.
9. Varney VA, Hamid QA, Gaga M, Ying S, Jacobson M, Frew AJ, et al. Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses. J Clin Invest 1993;92:644-51.
10. Iliopoulos O, Proud D, Adkinson NF Jr, Creticos PS, Norman PS, Kagey-Sobotka A, et al. Effects of immunotherapy on the early, late and rechallenge nasal reaction to provocation with allergen: changes in inflammatory mediators and cells. J Allergy Clin Immunol 1991;87:855-66.
11. Furin MJ, Norman PS, Creticos PS, Proud D, Kagey-Sobotka A, Lichtenstein LM, et al. Immunotherapy decreases antigen-induced eosinophil cell migration into the nasal cavity. J Allergy Clin Immunol 1991;88:27-32.
12. Otsuka H, Mezawa A, Ohnishi M, Okubo K, Seki H, Okuda M. Changes in nasal metachromatic cells during allergen immunotherapy. Clin Exp Allergy 1991;21:115-9.
13. Bousquet J, Hejjaoui A, Soussana M, Michel F-B. Double-blind, placebo controlled immunotherapy with mixed grass-pollen allergoids. IV. Comparison of the safety and efficacy of two dosages of a high-molecular-weight allergoid. J Allergy Clin Immunol 1990;85:490-7.
14. Bascom R, Wachs M, Naclerio RM, Pipkorn U, Galli SJ, Lichtenstein LM. Basophil influx occurs after nasal antigen challenge: effects of topical corticosteroid pretreatment. J Allergy Clin Immunol 1988;81:580-9.
15. Naclerio RM, Adkinson NF Jr, Creticos PS, Baroody FM, Hamilton RG, Norman PS. Intranasal steroids inhibit seasonal increases in ragweed-specific IgE antibodies. J Allergy Clin Immunol 1993;92:717-21.
16. Pipkorn U, Proud D, Lichtenstein LM, Kagey-Sobotka A, Norman PS, Naclerio RM. Inhibition of mediator release in allergic rhinitis by pretreatment with topical glucocorticosteroids. N Engl J Med 1987;316:1506-10.
17. Patterson R, Lieberman P, Irons J. Immunotherapy. In: Middleton E, Reed CE, Ellis EF, editors. Allergy: principles and practice. St. Louis: Mosby; 1978. p. 877-99.
18. Norman PS, Lichtenstein LM. Allergic rhinitis. In: Samter M, editor. Immunological diseases. Boston: Little Brown; 1978. p. 832-51.
19. Mosbech H, Østerballe O. Does the effect of immunotherapy last after termination of treatment? Follow-up study in patients with grass pollen rhinitis. Allergy 1988;43:523-9.
20. Norman PS, Creticos PS, Marsh DG, Adkinson NF Jr, Kagey-Sobotka A, Lichtenstein LM Two-year study of clinical results after discontinuation of ragweed allergoid immunotherapy [abstract]. J Allergy Clin Immunol 1988;81:294.
21. Golden DBK, Kwiterovich KA, Kagey-Sobotka A, Valentine MD, Lichtenstein LM. Discontinuing venom immunotherapy (VIT): determinants of clinical reactivity [abstract]. J Allergy Clin Immunol 1989;83:273.
22. Keating MU, Kagey-Sobotka A, Hamilton RG, Yunginger JW. Clinical and immunologic follow-up of patients who stop venom immunotherapy. J Allergy Clin Immunol 1991;88:339-48.
23. Reisman RE. Duration of venom immunotherapy. J Allergy Clin Immunol 1993;1991:831-6.
24. Müller U, Berchtold E, Helbling A. Honeybee venom allergy: results of a sting challenge 1 year after stopping successful venom immunotherapy in 86 patients. J Allergy Clin Immunol 1991;87:702-9.
25. Haugaard L, Nørregaard OFH, Dahl R. In-hospital sting challenge in insect venom-allergic patients after stopping venom immunotherapy. J Allergy Clin Immunol 1991;87:699-702.
26. Naclerio RM, Meier HL, Kagey-Sobotka A, Adkinson NF Jr, Meyers DA, Norman PS, et al. Mediator release after nasal airway challenge with allergen. Am Rev Respir Dis 1983;128:597-602.
27. Watase T, Okuda M. The effects of autonomotropic drugs on allergic nasal mucosa. Rhinology 1986;24:181-6.
28. Svenson C, Pipkorn U, Alkner U, Baumgarten CR, Persson CG. Topical vasoconstrictor (oxymetazoline) does not affect histamine-induced mucosal exudation of plasma in human nasal airways. Clin Exp Allergy 1992;22:411-6.
29. Majchel AM, Baroody FM, Kagey-Sobotka A, Lichtenstein LM, Naclerio RM. Effect of oxymetazoline on the early response to nasal challenge with antigen. J Allergy Clin Immunol 1993;92:767-70.
30. Siraganian RP. Refinements in the automated fluorometric histamine analysis system. J Immunol Methods 1975;7:283-90.
31. Imanari T, Kaizu T, Yoshida H, Yates K, Pierce JV, Pisano JJ. Radiochemical assays for human urinary, salivary and plasma kallikreins. In: Pisano JJ, Austen KF, editors. Chemistry and biology of the kallikrein-kinin system in health and disease. Washington (DC): Department of Health, Education and Welfare; 1976. p. 205-13. Department of Health, Education and Welfare Publication Number NIH 76-791.
32. Baumgarten CR, Nichols RC, Naclerio RM, Lichtenstein LM, Norman PS, Proud D. Plasma kallikrein during experimentally induced allergic rhinitis: role in kinin formation and contribution to TAME-esterase activity in nasal secretions. J Immunol 1986;137:977-82.
33. Baumgarten CR, Nichols RC, Naclerio RM, Proud D. Concentrations of glandular kallikrein in human nasal secretions during experimentally-induced allergic rhinitis. J Immunol 1986;137:1323-8.
34. Proud D, Togias A, Naclerio RM, Crush SA, Norman PS, Lichtenstein LM. Kinins are generated in vivo following nasal airway challenge of allergic individuals with allergen. J Clin Invest 1983;72:1678-85.
35. Iliopoulos O, Proud D, Adkinson NF Jr, Norman PS, Kagey-Sobotka A, Lichtenstein LM, et al. Relationship between the early, late and rechallenge reaction to nasal challenge with antigen. J Allergy Clin Immunol 1990;86:851-61.
36. Hamilton RG, Adkinson NF Jr. Measurement of total immunoglobulin E and allergen specific immunoglobulin E antibody. In: Rose NR, Conway deMacario E, Fahey JL, Friedman H, Penn GM, editors. Manual of clinical laboratory immunology. 4th ed. Washington (DC): American Society for Microbiology; 1992. p. 689-701.
37. Hamilton RG, Adkinson NF Jr. Measurement of allergen specific immunoglobulin G antibody. In: Rose NR, Conway deMacario E, Fahey JL, Friedman H, Penn GM, editors. Manual of clinical laboratory immunology. Washington (DC): American Society for Microbiology; 1992. p. 702-8.
38. Lichtenstein LM, Norman PS, Winkenwerder WL. A single year of immunotherapy for ragweed hay fever. Immunologic and clinical studies. Ann Intern Med 1971;75:663-71.
39. Hedlin G, Heilborn H, Lilja G, Norrlind K, Pegelow K-O, Schou C, et al. Long-term follow-up of patients treated with a three year course of cat or dog immunotherapy. J Allergy Clin Immunol 1995;96:879-85.